Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

HESHAM SIRSY MD LTD

NPI: 1982763108 · HENDERSON, NV 89052 · Pediatrics Physician · NPI assigned 12/06/2006

$1.79M
Total Medicaid Paid
41,665
Total Claims
34,972
Beneficiaries
44
Codes Billed
2018-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSIRSY, HESHAM (OWNER)
NPI Enumeration Date12/06/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 50 $2K
2019 5,463 $289K
2020 4,635 $229K
2021 6,316 $286K
2022 8,888 $373K
2023 8,951 $356K
2024 7,362 $252K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9,510 7,738 $555K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,254 3,545 $355K
90460 Immunization administration through 18 years of age via any route, first or only component 4,974 4,227 $195K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,338 1,936 $177K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,005 1,780 $174K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 939 841 $84K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,814 2,355 $79K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 551 506 $52K
90461 1,291 1,078 $40K
99058 1,128 962 $17K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 295 262 $11K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 180 132 $9K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 348 274 $7K
92567 604 506 $7K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 31 29 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 665 542 $4K
99223 Prolong inpt eval add15 m 30 24 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 600 526 $4K
94760 1,427 1,178 $2K
99235 16 12 $1K
86403 234 208 $1K
99239 Hospital discharge day management, more than 30 minutes 18 12 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 30 27 $491.96
90671 568 454 $449.78
88720 112 67 $213.64
96127 81 58 $211.41
96110 Developmental screening, with scoring and documentation, per standardized instrument 21 14 $103.60
90698 895 776 $88.88
96160 75 49 $88.59
90686 719 608 $41.06
90744 457 396 $0.00
90680 1,168 999 $0.00
90697 567 466 $0.00
90651 53 50 $0.00
90696 46 44 $0.00
90619 101 78 $0.00
90633 576 502 $0.00
90670 1,283 1,112 $0.00
90710 352 329 $0.00
90734 144 133 $0.00
90715 77 60 $0.00
90700 45 36 $0.00
90685 28 28 $0.00
90648 15 13 $0.00